Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin

Diabetes

Volumn 52, Issue 5, 2003, Pages 1081-1089

  Wiegman, Coen H ^a   Bandsma, Robert H J ^a   Ouwens, Margriet ^b   Van der Sluijs, Fjodor H ^a   Havinga, Rick ^a   Boer, Theo ^a   Reijngoud, Dirk Jan ^a   Romijn, Johannes A ^b   Kuipers, Folkert ^a,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CMCIV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; ISOPROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; GENETIC CODE; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; BASE SEQUENCE; CHOLESTEROL; CHOLESTEROL ESTERS; DNA PRIMERS; GENE EXPRESSION REGULATION; HYPERINSULINISM; INSULIN; KINETICS; LIPIDS; LIPOPROTEINS, VLDL; LIVER; MICE; MICE, OBESE; OLIGONUCLEOTIDE PROBES; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0037406445     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.5.1081     Document Type: Article

References (50)

1. Nestel P, Goldrick B: Obesity: changes in lipid metabolism and the role of insulin. Clin Endocrinol Metab 5:313-335, 1976
2. Kissebah AH, Alfarsi S, Evans DJ, Adams PW: Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 31:217-225, 1982
3. Jungermann K, Kietzmann T: Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31:255-260, 2000
4. Guzman M, Castro J: Zonation of fatty acid metabolism in rat liver. Biochem J 264:107-113, 1989
5. Picard F, Richard D, Huang Q, Deshaies Y: Effects of leptin adipose tissue lipoprotein lipase in the obese ob/ob mouse. Int J Obes Relat Metab Disord 22:1088-1095, 1998
6. Shimomura I, Bashmakov Y, Horton JD: Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028-30032, 1999
7. Hron WT, Sobocinski KA, Menahan LA: Enzyme activities of hepatic glucose utilization in the fed and fasting genetically obese mouse at 4-5 moths of age. Horm Metab Res Suppl 16:32-36, 1984
8. Reul BA, Becker DJ, Ongemba LN, Bailey CJ, Henquin JC, Brichard SM: Improvement of glucose homeostasis and hepatic insulin resistance in ob/ob mice given oral molybdate. J Endocrinol 155:55-64, 1997
9. Yen TT, Allan JA, Yu PL, Acton MA, Pearson DV: Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice. Biochim Biophys Acta 441:213-220, 1976
10. Memon RA, Fuller J, Moser AH, Smith PJ, Grunfeld C, Feingold KR: Regulation of putative fatty acid transporters and acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes 48:121-127, 1999
11. Lewis GF, Uffelman KD, Szeto LW, Steiner G: Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 42:833-842, 1993
12. Malmstrom R, Packard CJ, Watson TD, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Jarvinen H, Shepherd J, Taskinen MR: Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 17:1454-1465, 1997
13. Li X, Grundy SM, Patel SB: Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100. J Lipid Res 38:1277-1288, 1997
14. Camus MC, Aubert R, Bourgeois F, Herzog J, Alexiu A, Lemonnier D: Serum lipoprotein and apolipoprotein profiles of the genetically obese ob/ob mouse. Biochim Biophys Acta 961:53-64, 1988
15. Bartels ED, Lauritsen M, Nielsen LB: Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes 51:1233-1239, 2002
16. Hawkins M, Barzilai N, Liu R, Chen W, Rossetti L: Role of glucosanuine pathway in fat-induced insulin resistance. J Clin Invest 99:2173-2182, 1997
17. Rossetti L, Barzilai N, Chen W, Harris T, Yang D, Rogler CE: Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J Biol Chem 271:203-208, 1996
18. Li X, Catalina F, Grundy SM, Patel S: Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48 relative to B-100-containing lipoproteins. J Lipid Res 37:210-220, 1996
19. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917, 1959
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RL: Protein measurement with the folin reagens. J Biol Chem 193:265-275, 1951
21. Mensenkamp AR, Teusink B, Baller JF, Wolters H, Havinga R, Van Dijk KW, Havekes LM, Kuipers F: Mice expressing only the mutant APOE3Leiden gene show impaired VLDL secretion. Arterioscler Thromb Vasc Biol 21:1366-1372, 2001
22. Hellerstein MK, Neese RA: Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. Am J Physiol 263:E988-E1001, 1992
23. Jung HR, Turner SM, Neese RA, Young SG, Hellerstein MK: Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice. Biochem J 343:473-478, 1999
24. Neese RA, Faix D, Kletke C, Wu K, Wang AC, Shackleton CH, Hellerstein MK: Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. Am J Physiol 204:E136-E147, 1993
25. Lepage G, Roy CC: Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114-120, 1986
26. Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH: Elevated triglyceride-rich lipoproteins in diabetes: a study of apolipoprotein B-48. Acta Diabetol 33:205-210, 1996
27. Ouwens DM, van der Zon GC, Pronk GJ, Bos JL, Moller W, Cheatham B, Kahn CR, Maassen JA: A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2: evidence for IRS1-independent p21ras-GTP formation. J Biol Chem 269:33116-33122, 1994
28. Telting D, van der Zon GC, Dorrestijn J, Maassen JA: IRS-1 tyrosine phosphorylation reflects insulin-induced metabolic and mitogenic responses in 3T3-L1 pre-adipocytes. Arch Physiol Biochem 109:52-62, 2001
29. Bjorbaek C, Uotani S, da Silva B, Flier JS: Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272:32686-32695, 1997
30. Kellerer M, Koch M, Metzinger E, Mushack J, Capp E, Haring HU: Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathway. Diabetologia 40:1358-1362, 1997
31. Malmstrom R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Jarvmen H, Shepherd J, Taskinen MR: Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40:454-462, 1997
32. Khan B, Wilcox HG, Heimberg M: Cholesterol is required for secretion of very-low-density lipoprotein by rat liver. Biochem J 258:807-816, 1989
33. Mackinnon AM, Savage J, Gibson RA, Barter PJ: Secretion of cholesteryl ester-enriched very low density lipoproteins by the liver of cholesterol-fed rabbits. Atherosclerosis 54:145-155, 1985
34. Watts GF, Naoumova R, Cummings MH, Umpleby AM, Slavin BM, Sonksen PH, Thompson GR: Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects. Metabolism 44:1052-1057, 1995
35. Saad MJA, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR: Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90:1839-1849, 1992
36. Kerouz NJ, Horsch D, Pons S, Kahn CR: Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100:3164-3172, 1997
37. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL: Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6:77-86, 2000
38. Sparks JD, Phung TL, Bolognini M, Sparks C: Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with Brefeldin A and Wortmannin in primary cultures of rat hepatocytes. Biochem J 313:567-574, 1996
39. Phung TL, Roncone A, de Mesy Jensen KL, Sparks CE, Sparks JD: Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J Biol Chem 272:30693-30702, 1997
40. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Ramachandran C, Gresser MJ, Tremblay MI, Kennedy HP: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1423-1425, 1999
41. Taghibiglou C, Rashid-Kolvear R, Van Iderstine SC, Le-Tien H, Fantus IG, Lewis GF, Adeli K: Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1 B in a fructose-fed hamster model of insulin resistance. J Biol Chem 277:793-803, 2002
42. Harris RB: Parabiosis between db/db and ob/ob or db/+ mice. Endocrinology 140:138-145, 1999
43. Koo S-H, Dutcher AK, Towle HC: Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver. J Biol Chem 276:9437-9445, 2001
44. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, Arnot D, Uyeda K: A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 98:9116-9121, 2001
45. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K: Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem 277:3829-3835, 2002
46. Foretz M, Guichard C, Ferre P, Foufelle F: Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 96:12737-12742, 1999
47. Soukas A, Cohen P, Socci ND, Friedman JM: Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 14:963-980, 2000
48. Kakuma T, Lee Y, Higa M, Wang Z-W, Pan W, Shimomura I, Unger RH: Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci U S A 97:8536-8541, 2000
49. Tobe K, Suzuki R, Aoyama M, Yamauchi T, Kamon J, Kubota N, Tereuchi Y, Matsui J, Akanuma Y, Kimura S, Tanaka J, Abe M, Ohsumi J, Nogai R, Kadowaki T: Increased expression of the sterol regulatory element binding protein-1 gene in insulin receptor substrate-2 (-/-) mouse liver. J Biol Chem 276:38337-38340, 2001
50. Funahashi T, Giannoni F, DePaoli AM, Skarosi SF, Davidson NO: Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing. J Lipid Res 36:414-428, 1995